Views & Analysis After 2015's ‘breakthrough’ year for pharma approvals, will ... Roche's MS drug is among major drugs still to come in 2016.
Healthcare WHO agrees global effort to eliminate viral hepatitis by 203... All of the WHO's 194 member states have voted to eliminate viral hepatitis by 2030 as part of a global strategy.
Views & Analysis Hepatitis C: breaking down the stigma David Rowlands' latest online poll examines the impact of stigma on people diagnosed with hepatitis C virus (HCV).
R&D LSX2026: On a therapeutic vision for ocular disease, with Al... Alexander Gebauer, co-founder & executive chairman of Galimedix Therapeutics, discusses transforming treatment of major neurodegenerative eye diseases
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
